These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. DNA Methylome Signature in Synoviocytes From Patients With Early Rheumatoid Arthritis Compared to Synoviocytes From Patients With Longstanding Rheumatoid Arthritis. Ai R; Whitaker JW; Boyle DL; Tak PP; Gerlag DM; Wang W; Firestein GS Arthritis Rheumatol; 2015 Jul; 67(7):1978-80. PubMed ID: 25808728 [No Abstract] [Full Text] [Related]
26. Vasculitis and inflammatory arthritis. Watts RA; Scott DG Best Pract Res Clin Rheumatol; 2016 Oct; 30(5):916-931. PubMed ID: 27964796 [TBL] [Abstract][Full Text] [Related]
27. Acetylator phenotypes and rheumatoid arthritis. Ehrlich GE Ann Rheum Dis; 1986 Jul; 45(7):614. PubMed ID: 3740988 [No Abstract] [Full Text] [Related]
28. [Pathogenesis of bone involvement in patients with rheumatoid arthritis]. Lewicki M; Lewicka K; Goździk J; Kucharz EJ Przegl Lek; 2002; 59(11):912-5. PubMed ID: 12715721 [TBL] [Abstract][Full Text] [Related]
29. Remission in early rheumatoid arthritis. Ma MH; Scott IC; Kingsley GH; Scott DL J Rheumatol; 2010 Jul; 37(7):1444-53. PubMed ID: 20516031 [TBL] [Abstract][Full Text] [Related]
30. Rheumatoid Arthritis in the 21st Century: Treatment Patterns and Disease Activity States. Nikiphorou E; Rannio T; Sokka T J Rheumatol; 2015 Sep; 42(9):1542-4. PubMed ID: 26330124 [No Abstract] [Full Text] [Related]
31. Rheumatoid arthritis: concepts in evolution. Gall EP; Gall EA; Boyer JT Ariz Med; 1979 Jan; 36(1):55-9. PubMed ID: 420586 [No Abstract] [Full Text] [Related]
32. Anti B cell therapy proves successful in severe cases of rheumatoid arthritis. Marshall HE Trends Immunol; 2001 Jan; 22(1):13-4. PubMed ID: 11286684 [No Abstract] [Full Text] [Related]
33. The challenges of methotrexate pharmacogenetics in rheumatoid arthritis. Ranganathan P Pharmacogenomics; 2012 Mar; 13(4):377. PubMed ID: 22379994 [No Abstract] [Full Text] [Related]
34. Pim-2/mTORC1 Pathway Shapes Inflammatory Capacity in Rheumatoid Arthritis Synovial Cells Exposed to Lipid Peroxidations. Yin G; Li Y; Yang M; Cen XM; Xie QB Biomed Res Int; 2015; 2015():240210. PubMed ID: 26064888 [TBL] [Abstract][Full Text] [Related]
35. Gene analysis for exploring the effects of drugs in rheumatoid arthritis. Ospelt C; Neidhart M; Gay RE; Gay S Arthritis Rheum; 2005 Aug; 52(8):2248-56. PubMed ID: 16052564 [No Abstract] [Full Text] [Related]
36. Prognosis in rheumatoid arthritis. Bellamy N J Rheumatol; 1991 Sep; 18(9):1277-9. PubMed ID: 1757923 [No Abstract] [Full Text] [Related]
37. [Rheumatoid arthritis with vasculitis (malignant rheumatoid arthritis)--authors' case and review of the literature]. Tojo T; Honma M; Gomi J; Iri H Saishin Igaku; 1970 Aug; 25(8):1818-27. PubMed ID: 5458507 [No Abstract] [Full Text] [Related]
38. [Programs for continuing medical education: a session; 8. Pharmacotherapy of rheumatoid arthritis--interleukin-6 blocker made in Japan]. Nishimoto N Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):665-73. PubMed ID: 24796134 [No Abstract] [Full Text] [Related]
39. Therapeutic strategies for rheumatoid arthritis. Smolen JS; Steiner G Nat Rev Drug Discov; 2003 Jun; 2(6):473-88. PubMed ID: 12776222 [TBL] [Abstract][Full Text] [Related]
40. [Process of articular destruction in chronic rheumatoid arthritis and its treatment with drugs]. Abe T Nihon Naika Gakkai Zasshi; 1996 Sep; 85(9):1583-9. PubMed ID: 8999110 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]